CCL CCL NIFTY_SMALLNSE
Company Profile ↓Company Overview
CCL (CCL) is a publicly traded company listed on NSE with a market capitalization of ₹16,382.54 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.6%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 20.5%.
Net profit has compounded at 15.2% per year over the last five years.
Revenue has grown at a 17.6% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹4,457.37 Cr (+43.5% YoY); net profit ₹388.10 Cr.
- Trailing 12 Months Year-on-year growth — revenue +43.5%, earnings +25.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.6%, profit CAGR 15.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.60% |
| 1 Year: | 43.52% |
Compounded Profit Growth
| 5 Years: | 15.23% |
| 1 Year: | 25.06% |
Stock Price Performance
| 1 Year: | +40.42% |
| 6 Months: | +30.49% |
| 3 Months: | +12.62% |
| 1 Month: | +9.45% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)66.95 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 20.5%.
- Compounding revenue at 17.6% over 5 years.
- Profit CAGR of 15.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 52.8.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 520.00 Cr | 655.00 Cr | 608.00 Cr | 664.00 Cr | 727.00 Cr | 773.00 Cr | 738.00 Cr | 758.41 Cr | 835.85 Cr | 1,055.64 Cr | 1,127.00 Cr | 1,050.56 Cr | 1,224.44 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | 453.98 Cr | 465.11 Cr | 711.11 Cr | - | 661.18 Cr | 794.05 Cr |
| Gross Profit | - | - | - | - | - | - | - | 304.44 Cr | 370.73 Cr | 344.52 Cr | - | 389.38 Cr | 430.39 Cr |
| Operating Expenses | 407.00 Cr | 549.00 Cr | 498.00 Cr | 554.00 Cr | 609.00 Cr | 643.00 Cr | 601.00 Cr | 204.78 Cr | 234.41 Cr | 219.04 Cr | 930.00 Cr | 243.47 Cr | 279.00 Cr |
| Operating Income | 103.00 Cr | 84.00 Cr | 87.00 Cr | 89.00 Cr | 87.00 Cr | 107.00 Cr | 113.00 Cr | 99.65 Cr | 136.33 Cr | 125.48 Cr | 158.00 Cr | 145.91 Cr | 151.39 Cr |
| EBITDA | 113.00 Cr | 106.00 Cr | 110.00 Cr | 111.00 Cr | 118.00 Cr | 130.00 Cr | 137.00 Cr | 127.22 Cr | 167.09 Cr | 161.43 Cr | 197.00 Cr | 187.56 Cr | 193.77 Cr |
| Interest Expense | 11.00 Cr | 15.00 Cr | 18.00 Cr | 23.00 Cr | 21.00 Cr | 21.00 Cr | 27.00 Cr | 30.54 Cr | 34.25 Cr | 33.69 Cr | 33.00 Cr | 32.24 Cr | 30.20 Cr |
| Pretax Income | 95.00 Cr | 69.00 Cr | 70.00 Cr | 67.00 Cr | 70.00 Cr | 87.00 Cr | 87.00 Cr | 71.88 Cr | 105.88 Cr | 94.19 Cr | 127.00 Cr | 116.27 Cr | 123.14 Cr |
| Tax Provision | 9.50 Cr | 8.97 Cr | 9.10 Cr | 3.35 Cr | 4.90 Cr | 15.66 Cr | 13.05 Cr | 8.83 Cr | 4.01 Cr | 21.74 Cr | 26.67 Cr | 16.01 Cr | 8.61 Cr |
| Net Income | 85.00 Cr | 61.00 Cr | 61.00 Cr | 63.00 Cr | 65.00 Cr | 71.00 Cr | 74.00 Cr | 63.04 Cr | 101.87 Cr | 72.45 Cr | 101.00 Cr | 100.27 Cr | 114.53 Cr |
| Diluted EPS | 6.41 | 4.56 | 4.57 | 4.76 | 4.88 | 5.35 | 5.54 | 4.73 | 7.64 | 5.44 | 7.55 | 7.52 | 8.59 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 881.00 Cr | 932.00 Cr | 976.00 Cr | 1,138.00 Cr | 1,081.00 Cr | 1,139.00 Cr | 1,242.00 Cr | - | 2,071.22 Cr | 2,653.70 Cr | 3,105.75 Cr | 4,457.37 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 1,230.01 Cr | 1,709.36 Cr | 1,842.59 Cr | 2,903.93 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 841.21 Cr | 944.34 Cr | 1,263.16 Cr | 1,553.44 Cr |
| Operating Expenses | 709.00 Cr | 727.00 Cr | 744.00 Cr | 899.00 Cr | 836.00 Cr | 853.00 Cr | 945.00 Cr | - | 518.41 Cr | 613.87 Cr | 806.53 Cr | 972.43 Cr |
| Operating Income | 144.00 Cr | 177.00 Cr | 199.00 Cr | 205.00 Cr | 213.00 Cr | 239.00 Cr | 249.00 Cr | - | 322.80 Cr | 330.47 Cr | 456.63 Cr | 581.02 Cr |
| EBITDA | 171.00 Cr | 205.00 Cr | 232.00 Cr | 239.00 Cr | 245.00 Cr | 286.00 Cr | 298.00 Cr | - | 399.97 Cr | 448.95 Cr | 563.55 Cr | 741.37 Cr |
| Interest Expense | 14.00 Cr | 11.00 Cr | 11.00 Cr | 8.00 Cr | 8.00 Cr | 18.00 Cr | 17.00 Cr | - | 31.26 Cr | 75.04 Cr | 112.83 Cr | 128.75 Cr |
| Pretax Income | 134.00 Cr | 167.00 Cr | 189.00 Cr | 202.00 Cr | 209.00 Cr | 225.00 Cr | 235.00 Cr | - | 305.00 Cr | 276.24 Cr | 352.25 Cr | 460.70 Cr |
| Tax Provision | 40.20 Cr | 45.09 Cr | 54.81 Cr | 54.54 Cr | 54.34 Cr | 58.50 Cr | 51.70 Cr | - | 21.04 Cr | 26.16 Cr | 41.92 Cr | 72.59 Cr |
| Net Income | 94.00 Cr | 122.00 Cr | 135.00 Cr | 148.00 Cr | 155.00 Cr | 166.00 Cr | 182.00 Cr | - | 283.96 Cr | 250.08 Cr | 310.34 Cr | 388.10 Cr |
| Diluted EPS | 7.06 | 9.18 | 10.12 | 11.14 | 11.64 | 12.47 | 13.70 | 15.36 | 21.35 | 18.76 | 23.26 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 762.00 Cr | 801.00 Cr | 848.00 Cr | 1,134.00 Cr | 1,422.00 Cr | 1,509.00 Cr | 1,788.00 Cr | - | 2,596.93 Cr | 3,535.91 Cr | 4,240.98 Cr | 4,326.29 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 1,247.20 Cr | 1,741.07 Cr | 2,087.59 Cr | 2,209.27 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 82.60 Cr | 169.09 Cr | 96.94 Cr | 216.52 Cr |
| Inventory | - | - | - | - | - | - | - | - | 578.29 Cr | 788.42 Cr | 1,052.26 Cr | 1,042.12 Cr |
| Receivables | - | - | - | - | - | - | - | - | 441.41 Cr | 496.81 Cr | 690.28 Cr | 816.90 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 1,099.64 Cr | 1,862.10 Cr | 2,273.75 Cr | 1,981.74 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 834.98 Cr | 1,277.21 Cr | 1,636.67 Cr | 1,485.83 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | 200.84 Cr | 518.63 Cr | 556.30 Cr | 376.73 Cr |
| Total Debt | 229.00 Cr | 210.00 Cr | 142.00 Cr | 311.00 Cr | 416.00 Cr | 469.00 Cr | 559.00 Cr | - | 919.60 Cr | 1,621.33 Cr | 1,813.10 Cr | 1,324.36 Cr |
| Total Equity | 422.00 Cr | 510.00 Cr | 629.00 Cr | 740.00 Cr | 839.00 Cr | 929.00 Cr | 1,088.00 Cr | - | 1,497.29 Cr | 1,673.81 Cr | 1,967.23 Cr | 2,344.55 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 13.30 Cr | 13.35 Cr | 13.35 Cr | 13.35 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 105.00 Cr | 161.00 Cr | 102.00 Cr | 145.00 Cr | 162.00 Cr | 91.00 Cr | 171.00 Cr | - | 173.28 Cr | 55.38 Cr | 289.69 Cr | 858.29 Cr |
| Investing Cash Flow | -19.00 Cr | -87.00 Cr | -20.00 Cr | -247.00 Cr | -175.00 Cr | -88.00 Cr | -153.00 Cr | - | -332.15 Cr | -513.63 Cr | -415.91 Cr | -69.62 Cr |
| Financing Cash Flow | -93.00 Cr | -82.00 Cr | -84.00 Cr | 129.00 Cr | 42.00 Cr | -37.00 Cr | 64.00 Cr | - | 163.64 Cr | 558.51 Cr | 53.00 Cr | -756.92 Cr |
| Capital Expenditure | -21.00 Cr | -87.00 Cr | -18.00 Cr | -223.00 Cr | -242.00 Cr | -89.00 Cr | -155.00 Cr | - | -332.26 Cr | -513.27 Cr | -417.95 Cr | -69.80 Cr |
| Free Cash Flow | 84.00 Cr | 74.00 Cr | 84.00 Cr | -78.00 Cr | -80.00 Cr | 2.00 Cr | 16.00 Cr | - | -158.98 Cr | -457.89 Cr | -128.26 Cr | 788.49 Cr |
| Net Change in Cash | -8.00 Cr | -8.00 Cr | -2.00 Cr | 27.00 Cr | 29.00 Cr | -35.00 Cr | 82.00 Cr | - | 4.77 Cr | 100.26 Cr | -73.21 Cr | 31.75 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 40.6% | 35.6% | 40.7% | 34.9% |
| Operating Margin % | 16.3% | 19.0% | 20.4% | 18.0% | 19.7% | 21.0% | 20.0% | - | 15.6% | 12.5% | 14.7% | 13.0% |
| Net Margin % | 10.7% | 13.1% | 13.8% | 13.0% | 14.3% | 14.6% | 14.7% | - | 13.7% | 9.4% | 10.0% | 8.7% |
| ROE % | 22.3% | 23.9% | 21.5% | 20.0% | 18.5% | 17.9% | 16.7% | - | 19.0% | 14.9% | 15.8% | 16.6% |
| ROCE % | - | - | - | - | - | - | - | - | 18.3% | 14.6% | 17.5% | 20.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CCL
CCL Products (India) Ltd (BOM:519600) Q2 2026 Earnings Call Highlights: Robust Revenue Growth ...
CCL Products (India) Ltd (BOM:519600) reports a 52.7% revenue surge, while navigating market challenges and expanding its FMCG portfolio.
CCL — Frequently Asked Questions
What is the current share price of CCL?
As of 2026-07-16 05:21 IST, CCL trades at ₹1,226.90 on NSE. Its 52-week range is ₹827.02 to ₹1,229.70.
What is the market capitalisation of CCL?
CCL has a market capitalisation of ₹16,382.54 Cr on NSE.
What is the P/E ratio of CCL?
CCL trades at a trailing price-to-earnings (P/E) ratio of 52.75. Its price-to-book (P/B) ratio is 7.00.
What is the return on equity (ROE) of CCL?
CCL has a return on equity (ROE) of 16.55%. Its return on capital employed (ROCE) is 20.46%.
Is CCL a good stock to buy?
This page provides a data-driven analysis of CCL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.